Early Access — free while we kick the tires
EdgarHawk

Mark Voll

Chief Financial Officer

Officer

Latest: RenovoRx, Inc. CFO buying · May 2026

2 filings analyzed · 1 company · Latest 2026-05-21

Never miss a filing from Mark Voll

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
RenovoRx, Inc. RNXT 2 0 Net buying

Activity

May 2026
2026-05-21 RenovoRx, Inc. RNXT
low
Buy
25,000 shares
$19,690
Significance 3/10

CFO Mark Voll buys 25,000 shares of RNXT at $0.79; stock down 44.1% from 52-week high

Mark Voll, Chief Financial Officer, purchased 25,000 shares at $0.79 on 2026-05-19, increasing his holdings by 21.3% to 142,380 shares. The current price of $0.81 remains 44.1% below the 52-week high of $1.45, with the stock down 19.4% over the past 30 days and 13.9% over 90 days. His prior purchase at this ticker on 2026-03-20 returned -19.0% over 90 days, and his cross-ticker track record shows 1 prior buy with an average 90-day return of -19.0% and a 0.00% win rate. The company is unprofitable with net income of $-3.5M against quarterly revenue of $563.0K, though annual revenue growth reached 2511.6% year-over-year.

March 2026
2026-03-24 RenovoRx, Inc. RNXT
high
Buy
97,200 shares
Significance 6/10

CFO Mark Voll acquires 97,200 shares of RNXT; cluster buy with 2 others in 14 days

CFO Mark Voll purchased 97,200 shares on 2026-03-20, establishing a first position at the company. This buy occurs as part of a cluster pattern, with 2 other insiders also purchasing within the past 14 days. The company generated $266,000.00 in revenue in its latest quarter but reported a net loss of $-2.9M and carries a market cap of $39.6M. The stock is currently trading at $1.08, down 23.9% from its 52-week high but up 18.3% over 30 days and up 20.6% over 90 days. Simultaneous buying by multiple insiders at an unprofitable company warrants examination of whether the recent price recovery reflects changing fundamentals or represents informed conviction about turnaround prospects.

Related insiders